899429-04-0 Usage
Uses
Used in Pharmaceutical Industry:
6-Bromo-8-methyl[1,2,4]triazolo[1,5-a]pyridine is used as a pharmaceutical agent for its potential anti-inflammatory properties, offering a new avenue for the treatment of inflammation-related conditions. Its ability to modulate inflammatory pathways makes it a candidate for further exploration and development in this therapeutic area.
Used in Anticancer Applications:
In the field of oncology, 6-Bromo-8-methyl[1,2,4]triazolo[1,5-a]pyridine is utilized as an anticancer agent, targeting various types of cancer cells. Its potential to disrupt cancer cell proliferation and induce apoptosis positions it as a valuable compound for the development of novel cancer therapies.
Used in Antiviral Applications:
6-Bromo-8-methyl[1,2,4]triazolo[1,5-a]pyridine is employed as an antiviral agent, leveraging its ability to inhibit viral replication and reduce viral load in infected cells. This makes it a candidate for the development of new antiviral drugs to combat viral infections.
Used in Agrochemical Industry:
In the agrochemical sector, 6-Bromo-8-methyl[1,2,4]triazolo[1,5-a]pyridine is used as a bioactive compound for its potential to control pests and diseases in agriculture. Its ability to target and disrupt biological processes in pests and pathogens makes it a candidate for the development of new agrochemicals to improve crop protection and yield.
Check Digit Verification of cas no
The CAS Registry Mumber 899429-04-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,9,4,2 and 9 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 899429-04:
(8*8)+(7*9)+(6*9)+(5*4)+(4*2)+(3*9)+(2*0)+(1*4)=240
240 % 10 = 0
So 899429-04-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H6BrN3/c1-5-2-6(8)3-11-7(5)9-4-10-11/h2-4H,1H3
899429-04-0Relevant articles and documents
[1,2,4]TRIAZOLO[1,5-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS
-
Page/Page column 139; 140, (2018/02/28)
Disclosed are compounds of Formula (I) or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
(2S,3S)-3-amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-[1, 2,4]triazolo[1,5-a]-pyridin-6-ylphenyl)butanamide: A selective α-amino amide dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
Edmondson, Scott D.,Mastracchio, Anthony,Mathvink, Robert J.,He, Jiafang,Harper, Bart,Park, You-Jung,Beconi, Maria,Di Salvo, Jerry,Eiermann, George J.,He, Huaibing,Leiting, Barbara,Leone, Joseph F.,Levorse, Dorothy A.,Lyons, Kathryn,Patel, Reshma A.,Patel, Sangita B.,Petrov, Aleksandr,Scapin, Giovanna,Shang, Jackie,Roy, Ranabir Sinha,Smith, Aaron,Wu, Joseph K.,Xu, Shiyao,Zhu, Bing,Thornberry, Nancy A.,Weber, Ann E.
, p. 3614 - 3627 (2007/10/03)
A series of β-substituted biarylphenylalanine amides were synthesized and evaluated as inhibitors of dipeptidyl peptidase IV (DPP-4) for the treatment of type 2 diabetes. Optimization of the metabolic profile of early analogues led to the discovery of (2S